Company Analysis OrbusNeich Medical Group Holdings Limited
1. Summary
Advantages
- Price (3.59 HK$) is less than fair price (8.5 HK$)
- Current debt level 0.1183% is below 100% and has decreased over 5 years from 41.54%.
- The company's current efficiency (ROE=10.43%) is higher than the sector average (ROE=4.24%)
Disadvantages
- Dividends (5.56%) are below the sector average (5.6%).
- The stock's return over the last year (7.81%) is lower than the sector average (13.96%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| OrbusNeich Medical Group Holdings Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.8% | -2.3% | -1.5% |
| 90 days | 1.7% | -3.6% | -0.7% |
| 1 year | 7.8% | 14% | 30.5% |
6929 vs Sector: OrbusNeich Medical Group Holdings Limited has significantly underperformed the "Healthcare" sector by -6.16% over the past year.
6929 vs Market: OrbusNeich Medical Group Holdings Limited has significantly underperformed the market by -22.71% over the past year.
Stable price: 6929 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 6929 with weekly volatility of 0.1502% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (3.59 HK$) is lower than the fair price (8.5 HK$).
Price significantly below the fair price: The current price (3.59 HK$) is 136.8% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (9.93) is lower than that of the sector as a whole (31.87).
P/E vs Market: The company's P/E (9.93) is lower than that of the market as a whole (26.88).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1) is lower than that of the sector as a whole (2.54).
P/BV vs Market: The company's P/BV (1) is lower than that of the market as a whole (1.66).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.4) is lower than that of the sector as a whole (6.25).
P/S vs Market: The company's P/S indicator (2.4) is lower than that of the market as a whole (2.66).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (197.59) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (197.59) is higher than that of the market as a whole (9.93).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 859.93% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (859.93%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-25.07%).
5.4. ROE
ROE vs Sector: The company's ROE (10.43%) is higher than that of the sector as a whole (4.24%).
ROE vs Market: The company's ROE (10.43%) is higher than that of the market as a whole (3.92%).
5.5. ROA
ROA vs Sector: The company's ROA (9.44%) is higher than that of the sector as a whole (3.29%).
ROA vs Market: The company's ROA (9.44%) is higher than that of the market as a whole (3.34%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 5.56% is below the average for the sector '5.6%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.56% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 5.56% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (26.73%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
